证券代码：600249 证券简称：两面针 公告编号：临2025-034 柳州两面针股份有限公司 2025 年第三季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 柳州两面针股份有限公司（以下简称"公司"）根据上海证券交 易所《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第 十三号——化工》的要求，现将 2025 年第三季度主要经营数据披露如 下： 三、 主要原材料的价格波动情况 | 对应 | 主要 | 年 2025 | 7-9 | 月 | 年 2024 | 月 7-9 | 同比变 | 环比变 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 产品 | 原材料 | 平均进价 | | | 平均进价 | | 动比率 | 动比率 | | | | （元/吨） | | | （元/吨） | | （%） | （%） | | 家用/旅游牙膏 | 二氧化硅 | 8,788.25 | | | 9,135.49 | | -3.80 | -0 ...

Financial Performance - The company's operating revenue for the third quarter was CNY 293,134,925.09, representing a year-on-year increase of 6.83%[4] - The total profit for the third quarter decreased by 67.57% to CNY 35,913,444.14 compared to the same period last year[4] - The net profit attributable to shareholders was CNY 28,574,484.42, down 67.34% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 10,693,000.33, a decrease of 44.16% compared to the previous year[4] - The basic earnings per share for the third quarter was CNY 0.0500, down 68.75% from CNY 0.1600 in the same period last year[5] - Net profit for the first three quarters of 2025 was ¥24,599,085.05, a decrease from ¥84,775,972.19 in 2024, reflecting a decline of approximately 70.0%[20] - Basic earnings per share for the first three quarters of 2025 were ¥0.0427, down from ¥0.1528 in the same period of 2024[21] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,768,290,194.40, an increase of 1.74% from the end of the previous year[5] - The company's total equity stood at ¥2,190,169,248.32, slightly up from ¥2,182,268,163.27[18] - Total liabilities increased to ¥578,120,946.08 from ¥538,655,408.33, representing a growth of approximately 7.3%[18] - The company's current assets as of September 30, 2025, amount to ¥2,034,354,779.26, an increase from ¥1,986,779,830.53 as of December 31, 2024, reflecting a growth of approximately 2.8%[16] - The total non-current assets are reported at ¥733,935,415.14, slightly down from ¥734,143,741.07 in the previous period[16] Cash Flow - The cash flow from operating activities for the year-to-date was CNY 53,798,729.28, reflecting a substantial increase of 1,282.91% compared to the previous year[4] - Net cash flow from operating activities was 53,798,729.28, a significant increase from 3,890,253.50 in the previous period[23] - Total cash inflow from operating activities amounted to 883,008,249.43, while cash outflow was 829,209,520.15, resulting in a net increase[23] - Cash flow from investing activities showed a net outflow of -23,482,630.62, compared to -5,394,680.62 previously[24] - Cash inflow from financing activities was 75,000,000.00, an increase from 65,000,000.00 in the prior period[24] Shareholder Information - The total number of shareholders at the end of the reporting period is 10, with the largest shareholder being Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holding 183,360,652 shares, representing 33.34% of the total shares[13] - The company has a total of 10,959,167 shares held by Liuzhou Economic Development Investment Co., Ltd., accounting for 1.99% of the total shares[13] - The company has no significant changes in the shareholding structure among the top 10 shareholders compared to the previous period[14] Operational Insights - The company experienced a decline in investment income, which significantly impacted net profits for both the current quarter and year-to-date periods[10] - The company has not disclosed any new strategies or significant developments in product or technology research during this reporting period[15] - There are no reminders or additional important information regarding the company's operational situation for investors[15] Revenue and Costs - Total revenue for the first three quarters of 2025 reached ¥815,380,039.39, an increase from ¥791,383,833.34 in the same period of 2024, representing a growth of approximately 3.8%[19] - Total operating costs for the first three quarters of 2025 were ¥809,901,938.15, compared to ¥781,331,108.23 in 2024, indicating an increase of about 3.7%[19] Research and Development - Research and development expenses increased to ¥13,851,976.90 in 2025 from ¥11,017,341.20 in 2024, marking a rise of about 25.6%[20]

Core Viewpoint - The company reported a revenue increase in Q3 2025 but experienced a significant decline in net profit compared to the previous year [1] Financial Performance - In Q3 2025, the company achieved a revenue of 293 million yuan, representing a year-on-year growth of 6.83% [1] - The net profit attributable to shareholders was 28.57 million yuan, showing a decline of 67.34% year-on-year [1] - Basic earnings per share for Q3 2025 were 0.05 yuan [1] Year-to-Date Performance - For the first three quarters of 2025, the company reported a total revenue of 815 million yuan, which is a year-on-year increase of 3.03% [1] - The net profit attributable to shareholders for the first three quarters was 23.49 million yuan, reflecting a year-on-year decrease of 72.04% [1] - Basic earnings per share for the first three quarters were 0.0427 yuan [1]

Market Overview - The personal care products sector experienced a decline of 0.34% on October 24, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with the following notable changes: - Baiya Co., Ltd. (003006) closed at 22.77, down 1.94% with a trading volume of 63,800 shares and a turnover of 146 million [1] - Yanjing Co., Ltd. (300658) closed at 8.46, down 1.40% with a trading volume of 168,400 shares and a turnover of 145 million [1] - Jeya Co., Ltd. (301108) closed at 35.76, down 0.91% with a trading volume of 49,800 shares and a turnover of 185 million [1] - Other stocks like Beijia Co. (603059) and Zhongshun Jierou (002511) also saw minor declines [1] Capital Flow - The personal care products sector saw a net inflow of 2.96 million from institutional investors and a net inflow of 4.80 million from retail investors, while retail investors experienced a net outflow of 7.76 million [3] - Notable capital flows for specific stocks include: - Wanjian Medical (300888) had a net inflow of over 9.34 million from institutional investors, but a net outflow of 11.91 million from retail investors [3] - Liangmian Needle (600249) saw a net inflow of 7.46 million from institutional investors, while retail investors had a net inflow of 1.39 million [3] - Baiya Co., Ltd. (003006) had a net inflow of 5.32 million from institutional investors but a significant net outflow of 4.30 million from retail investors [3]

Market Overview - The personal care products sector increased by 0.82% on October 23, with Baiya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index closed at 13025.45, also up 0.22% [1] Stock Performance - Baiya Co., Ltd. (003006) closed at 23.22, up 2.74% with a trading volume of 73,700 shares and a turnover of 171 million yuan [1] - Beijia Co. (603059) closed at 34.56, up 1.98% with a trading volume of 38,800 shares and a turnover of 134 million yuan [1] - Dengkang Oral (001328) closed at 39.14, up 1.90% with a trading volume of 28,400 shares and a turnover of 112 million yuan [1] - Zhongshun Jiesang (002511) closed at 8.48, up 1.68% with a trading volume of 83,800 shares and a turnover of 70.46 million yuan [1] - Yanjing Co. (300658) closed at 8.58, up 1.30% with a trading volume of 175,500 shares and a turnover of 146 million yuan [1] - Other notable performances include Haoyue Nursing (605009) at 33.36, up 0.97%, and Runben Co. (603193) at 26.54, up 0.38% [1] Capital Flow - The personal care products sector saw a net inflow of 17.6 million yuan from institutional investors, while retail investors contributed a net inflow of 19.3 million yuan [2] - However, speculative funds experienced a net outflow of 36.9 million yuan [2] Detailed Capital Flow Analysis - Baiya Co., Ltd. had a net inflow of 19.28 million yuan from institutional investors, while it faced a net outflow of 11.41 million yuan from speculative funds [3] - Beijia Co. experienced a net inflow of 16.18 million yuan from institutional investors but a net outflow of 22.75 million yuan from speculative funds [3] - Dengkang Oral saw a net inflow of 4.54 million yuan from institutional investors, with minor outflows from other categories [3] - Zhongshun Jiesang had a net inflow of 1.60 million yuan from institutional investors, while speculative funds showed a net outflow [3]

Market Overview - The personal care products sector experienced a decline of 0.63% on October 22, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Jieya Co., Ltd. increasing by 4.97% to a closing price of 36.95 [1] - Baiya Co., Ltd. closed at 22.60, down 1.95%, with a trading volume of 76,400 shares and a transaction value of 173 million yuan [2] - Other notable declines included Duncon Oral Care down 1.36% and Stable Medical down 0.86% [2] Capital Flow - The personal care products sector saw a net outflow of 26.09 million yuan from institutional investors, while retail investors had a net inflow of 21.82 million yuan [2] - The capital flow data indicates that retail investors were more active in the market compared to institutional investors [3] Individual Stock Capital Flow - For individual stocks, the net inflow for Jieya Co., Ltd. was 8.44 million yuan from institutional investors, while it faced a net outflow of 20.48 million yuan from retail investors [3] - Duncon Oral Care had a net inflow of 1.64 million yuan from institutional investors, but also saw outflows from retail investors [3]

Market Overview - The personal care products sector increased by 0.31% compared to the previous trading day, with Liangmianzhen leading the gains [1] - The Shanghai Composite Index closed at 3916.33, up 1.36%, while the Shenzhen Component Index closed at 13077.32, up 2.06% [1] Stock Performance - Liangmianzhen (600249) closed at 6.37, with a rise of 4.60% and a trading volume of 445,700 shares, amounting to a transaction value of 280 million yuan [1] - Yanjing Co. (300658) closed at 8.48, up 3.92%, with a trading volume of 120,400 shares and a transaction value of 100 million yuan [1] - Baiya Co. (003006) closed at 23.05, increasing by 2.13%, with a trading volume of 44,200 shares and a transaction value of 101 million yuan [1] - Other notable stocks include Jieya Co. (301108) at 35.20 (+1.38%), and Zhongshun Jiesang (002511) at 8.38 (+0.96%) [1] Capital Flow - The personal care products sector saw a net inflow of 6.91 million yuan from institutional investors, while retail investors contributed a net inflow of 35.52 million yuan [2] - However, there was a net outflow of 42.43 million yuan from speculative funds [2] Individual Stock Capital Flow - Liangmianzhen (600249) had a net inflow of 42.22 million yuan from institutional investors, while it experienced a net outflow of 10.38 million yuan from speculative funds [3] - Baiya Co. (003006) saw a net inflow of 7.09 million yuan from institutional investors, with a net outflow of 9.76 million yuan from speculative funds [3] - Yanjing Co. (300658) had a net inflow of 5.25 million yuan from institutional investors, but a net outflow of 9.95 million yuan from speculative funds [3]

Core Viewpoint - The A-share market is experiencing a surge in flu-related stocks, driven by rising flu activity in southern provinces and the emergence of the H3N2 strain, which has led to increased investor interest in pharmaceutical companies [1][2] Company Performance - **Jinshi Yiyao**: Increased by 13.44%, with a total market value of 4.644 billion [2] - **Guangji Pharmaceutical**: Rose by 9.97%, total market value of 2.448 billion [2] - **Te Yi Pharmaceutical**: Gained 8.78%, market value of 5.209 billion [2] - **Hualan Biological Engineering**: Up by 8.59%, with a market value of 12.9 billion [2] - **Lingkang Pharmaceutical**: Increased by 7.01%, market value of 4.291 billion [2] - **Hengdi Pharmaceutical**: Rose by 6.60%, market value of 5.466 billion [2] - **Innotec**: Increased by 5.37%, market value of 4.459 billion [2] - **Weikang Pharmaceutical**: Up by 4.76%, market value of 3.471 billion [2] - **Yirui Biological**: Increased by 4.67%, market value of 4.359 billion [2] Market Trends - The China CDC reported a slow increase in respiratory disease cases nationwide, with flu activity rising in southern provinces and remaining low in northern regions [1] - Experts suggest that the flu season may arrive earlier this year, with a potential increase in infection rates due to lower immunity against the H3N2 strain [1]

Market Overview - The Shanghai Composite Index rose by 0.63% on October 20, with 26 out of 28 sectors experiencing gains, led by the communication and coal industries, which increased by 3.21% and 3.04% respectively [1] - The market saw a net outflow of 4.601 billion yuan in major funds, with 12 sectors recording net inflows, primarily in the communication sector, which attracted 4.397 billion yuan [1] Sector Performance - The communication sector had the highest net inflow of funds, contributing to its 3.21% increase, while the coal sector followed with a net inflow of 1.148 billion yuan [1] - Conversely, the non-ferrous metals sector experienced the largest net outflow, totaling 4.699 billion yuan, followed by the computer sector with a net outflow of 2.390 billion yuan [1] Beauty and Personal Care Industry - The beauty and personal care sector declined by 0.38%, with a net outflow of 24.996 million yuan [2] - Among the 29 stocks in this sector, 15 saw gains while 12 experienced declines [2] - The top net inflow stock was Shanghai Jahwa, with an inflow of 22.996 million yuan, followed by Liangmianzhen and Jiaheng Jiahua with inflows of 12.992 million yuan and 6.235 million yuan respectively [2] Individual Stock Performance - The stocks with the highest net outflows included Proya, Aimeike, and Huaxi Biology, with outflows of 26.186 million yuan, 23.826 million yuan, and 9.397 million yuan respectively [2] - A detailed table of stock performance indicates various changes in price and turnover rates, highlighting the dynamics within the beauty and personal care sector [3]

Market Overview - The personal care products sector experienced a decline of 0.29% on October 20, with Dengkang Oral Care leading the drop [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Jeya Co. rising by 3.83% to a closing price of 34.72, and Dengkang Oral Care falling by 3.21% to 39.56 [1][2] - Other notable performers included Runben Co. with a 2.97% increase and Liangmian Needle with a 2.87% increase [1][2] Trading Volume and Value - Jeya Co. had a trading volume of 31,000 shares and a transaction value of 108 million yuan, while Dengkang Oral Care had a trading volume of 25,900 shares and a transaction value of 104 million yuan [1][2] Capital Flow - The personal care products sector saw a net inflow of 24.78 million yuan from institutional investors, while retail investors experienced a net outflow of 11.31 million yuan [2][3] - Major stocks like Liangmian Needle had a net inflow of 16.20 million yuan from institutional investors, while Dengkang Oral Care had a net inflow of 4.53 million yuan [3]